A detailed history of Brevan Howard Capital Management LP transactions in Dexcom Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 26,531 shares of DXCM stock, worth $1.54 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
26,531
Previous 4,939 437.17%
Holding current value
$1.54 Million
Previous $431,000 314.15%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$66.46 - $89.53 $1.44 Million - $1.93 Million
21,592 Added 437.17%
26,531 $1.79 Million
Q2 2025

Aug 14, 2025

BUY
$59.83 - $87.57 $295,500 - $432,508
4,939 New
4,939 $431,000
Q4 2024

Feb 14, 2025

BUY
$65.68 - $81.01 $220,028 - $271,383
3,350 New
3,350 $260,000
Q4 2023

Feb 14, 2024

BUY
$75.49 - $124.16 $948,531 - $1.56 Million
12,565 New
12,565 $1.56 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $22.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.